Lantern Pharma Inc. (LTRN): Total Assets
$11.04M
As of 2025-12-31
$8.60M
As of 2026-06-30
-42.8%
3-year compound annual growth
-11.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.04M | -56.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $25.57M | -41.4% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $43.65M | -25.8% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $58.84M | -20.4% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $73.95M | +263.2% | 2023-03-20, Balance as of period end |
| 2020-12-31 | $20.36M | n/m | 2022-03-10, Balance as of period end |
| 2019-12-31 | $1.43M | n/a | 2021-03-10, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $11.04M | -56.8% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $11.06M | +265.8% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $11.09M | +279.5% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $11.12M | -31.6% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $11.45M | n/m |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $10.62M | -57.5% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.58M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $11.58M | +74.9% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
Compare LTRN, DCOY, MIRA, MTVA side by side · Screen every company in Pharmaceutical Preparations ↗